Vifor Pharma AG buy Slaandjivaa
Start price
12.01.17
/
50%
€103.74
Target price
11.09.17
€115.00
Performance (%)
-11.06%
End price
11.09.17
€90.44
Summary
This prediction ended on 11.09.17 with a price of €90.44. The prediction for Vifor Pharma AG disappointed with a performance of -11.06%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vifor Pharma AG | - | - | - | - |
| iShares Core DAX® | 3,01 % | 1,44 % | 22,85 % | 50,83 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % | 37,06 % | 80,37 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % | 53,86 % | 60,40 % |
| iShares S&P 500 | 2,38 % | 0,24 % | 29,01 % | 59,98 % |
Comments by Slaandjivaa for this prediction
In the thread Vifor Pharma AG diskutieren
Galileo Galenica
Decet
(Laufzeit überschritten)